Harstrick A - Search Results

1

Cetuximab monotherapy and cetuximab plus irinotecan in irinotecan-refractory metastatic colorectal cancer.

Cunningham D, Humblet Y, Siena S, Khayat D, Bleiberg H, Santoro A, Bets D, Mueser M, Harstrick A, Verslype C, Chau I, Van Cutsem E. Cunningham D, et al. Among authors: harstrick a. N Engl J Med. 2004 Jul 22;351(4):337-45. doi: 10.1056/NEJMoa033025. N Engl J Med. 2004. PMID: 15269313 Free article. Clinical Trial.

2

Phase I/II study of cetuximab in combination with cisplatin or carboplatin and fluorouracil in patients with recurrent or metastatic squamous cell carcinoma of the head and neck.

Bourhis J, Rivera F, Mesia R, Awada A, Geoffrois L, Borel C, Humblet Y, Lopez-Pousa A, Hitt R, Vega Villegas ME, Duck L, Rosine D, Amellal N, Schueler A, Harstrick A. Bourhis J, et al. Among authors: harstrick a. J Clin Oncol. 2006 Jun 20;24(18):2866-72. doi: 10.1200/JCO.2005.04.3547. Epub 2006 May 22. J Clin Oncol. 2006. PMID: 16717293 Clinical Trial.

3

Irinotecan in the treatment of colorectal cancer: clinical overview.

Vanhoefer U, Harstrick A, Achterrath W, Cao S, Seeber S, Rustum YM. Vanhoefer U, et al. Among authors: harstrick a. J Clin Oncol. 2001 Mar 1;19(5):1501-18. doi: 10.1200/JCO.2001.19.5.1501. J Clin Oncol. 2001. PMID: 11230497 Review.

4

New systemic frontline treatment for metastatic colorectal carcinoma.

Braun AH, Achterrath W, Wilke H, Vanhoefer U, Harstrick A, Preusser P. Braun AH, et al. Among authors: harstrick a. Cancer. 2004 Apr 15;100(8):1558-77. doi: 10.1002/cncr.20154. Cancer. 2004. PMID: 15073842 Free article. Review.

5

Phase II multicenter study of the antiepidermal growth factor receptor monoclonal antibody cetuximab in combination with platinum-based chemotherapy in patients with platinum-refractory metastatic and/or recurrent squamous cell carcinoma of the head and neck.

Baselga J, Trigo JM, Bourhis J, Tortochaux J, Cortés-Funes H, Hitt R, Gascón P, Amellal N, Harstrick A, Eckardt A. Baselga J, et al. Among authors: harstrick a. J Clin Oncol. 2005 Aug 20;23(24):5568-77. doi: 10.1200/JCO.2005.07.119. Epub 2005 Jul 11. J Clin Oncol. 2005. PMID: 16009950 Clinical Trial.

6

Capecitabine and irinotecan as first-line chemotherapy in patients with metastatic colorectal cancer: results of an extended phase I study.

Tewes M, Schleucher N, Achterrath W, Wilke HJ, Frings S, Seeber S, Harstrick A, Rustum YM, Vanhoefer U. Tewes M, et al. Among authors: harstrick a. Ann Oncol. 2003 Sep;14(9):1442-8. doi: 10.1093/annonc/mdg376. Ann Oncol. 2003. PMID: 12954586 Free article. Clinical Trial.

7

Phase I study of a weekly schedule of irinotecan, high-dose leucovorin, and infusional fluorouracil as first-line chemotherapy in patients with advanced colorectal cancer.

Vanhoefer U, Harstrick A, Köhne CH, Achterrath W, Rustum YM, Seeber S, Wilke H. Vanhoefer U, et al. Among authors: harstrick a. J Clin Oncol. 1999 Mar;17(3):907-13. doi: 10.1200/JCO.1999.17.3.907. J Clin Oncol. 1999. PMID: 10071283 Clinical Trial.

8

Modulation of 5-fluorouracil with methotrexate and low-dose N-(phosphonacetyl)-L-aspartate in patients with advanced colorectal cancer. Results of a phase II study.

Köhne CH, Harstrick A, Hiddemann W, Schöffski P, Wilke H, Bokemeyer C, Dörken B, Schmoll HJ. Köhne CH, et al. Among authors: harstrick a. Eur J Cancer. 1997 Oct;33(11):1896-9. doi: 10.1016/s0959-8049(97)00256-6. Eur J Cancer. 1997. PMID: 9470854 Clinical Trial.

9

Phase I/II study of capecitabine and vinorelbine in pretreated patients with metastatic breast cancer.

Welt A, von Minckwitz G, Oberhoff C, Borquez D, Schleucher R, Loibl S, Harstrick A, Kaufmann M, Seeber S, Vanhoefer U. Welt A, et al. Among authors: harstrick a. Ann Oncol. 2005 Jan;16(1):64-9. doi: 10.1093/annonc/mdi024. Ann Oncol. 2005. PMID: 15598940 Free article. Clinical Trial.

10

Infusional 5-fluorouracil/leucovorin plus paclitaxel and cisplatin in the first-line treatment of metastatic breast cancer: results of a phase II study.

Klaassen U, Wilke H, Müller C, Borquez D, Harstrick A, Seeber S. Klaassen U, et al. Among authors: harstrick a. Semin Oncol. 1997 Oct;24(5 Suppl 17):S17-58-S17-60. Semin Oncol. 1997. PMID: 9374095 Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

105 results

Search Page

Filters